372 Neo-adjuvant chemotherapy in locally advanced beast cancer (LABC): FEC (5FU, epirubicin, cyclophosphamide) vs high dose intensity EC+G-CSF (Filgrastim). An EORTC—NCIC—SAKK study. Preliminary results of dose intensity (DI)
- 30 November 1995
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 31, S81
- https://doi.org/10.1016/0959-8049(95)95625-g
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: